Company / Assets per Share
Neurogene Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$19.43
FY2025
5-year range
$3.31 / $26.18
FY2021-FY2025
Trend
-25.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $6.25 to $19.43 over the past 6 years.
Based on SEC 10-K filings.
19.43 in FY2025.
Improved from $6.25 to $19.43 over the past 6 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 25.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.43 | -25.8% |
| FY2024 | $26.18 | +319.1% |
| FY2019 | $6.25 | +88.9% |
| FY2018 | $3.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026